GGrantIndex
Sort

11,323 grants matching glioblastoma

Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma

$177,362
Michael J Eck · Brigham And Women'S Hospital · U19 · FY2024 · CA

Core 1: Biospecimen and Pathology Core

$177,356
William H. Yong · University Of California Los Angeles · P50 · FY2017 · CA

Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell

$177,353
Mihoko Kai · Johns Hopkins University · R21 · FY2016 · CA

Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma

$177,113
Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

The Role of Eph-ephrin Interactions in Glioma Migration

$177,053
Peter D Canoll · Columbia University Health Sciences · K08 · FY2006 · NS

Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma

$177,027
Vishwanath R Iyer · University Of Texas At Austin · R21 · FY2016 · CA

The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis

$177,012
Odessa Yabut · University Of California, San Francisco · K01 · FY2017 · CA

The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis

$177,012
Odessa Yabut · University Of California, San Francisco · K01 · FY2016 · CA

Receptor Tyrosine Kinase/PTEN Interactions in Gliomas

$177,008
University Of Virginia Charlottesville · R01 · FY2005 · NS

Gene Therapy for Glioma

$176,906
Cedars-Sinai Medical Center · R21 · FY2004 · NS

Gene Therapy for Glioma

$176,906
Cedars-Sinai Medical Center · R21 · FY2003 · NS

Role of m6A RNA methylation in Regulation of Translation in Human Glioblastoma

$176,654
Nikolaos Tapinos · Rhode Island Hospital · R21 · FY2020 · CA

Evolution of cancer-specific molecular requirements for glioblastoma multiforme (

$176,645
Patrick Paddison · Fred Hutchinson Cancer Research Center · R21 · FY2013 · CA

CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma

$176,526
Qin Yu · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA

Developing a NF-κB/GADD45b targeting strategy for glioblastoma

$176,447
Krishna Pl Bhat · University Of Tx Md Anderson Can Ctr · R21 · FY2020 · CA

BIOINFORMATICS

$176,407
Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2010 · CA

Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4

$176,218
Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2023 · CA

New Cancer Therapeutic Target

$176,175
Michael J Spinella · Dartmouth College · R21 · FY2014 · CA

An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM

$176,146
Behnam Badie · Beckman Research Institute/City Of Hope · U19 · FY2025 · CA

Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma

$176,131
Sandeep Burma · Ut Southwestern Medical Center · R21 · FY2016 · CA

Core C - Clinical Trials

$176,102
John M Buatti · University Of Iowa · P01 · FY2020 · CA

Core C - Clinical Trials

$176,102
John M Buatti · University Of Iowa · P01 · FY2021 · CA

Targeting the neuronal microenvironment in glioblastoma

$176,101
Michelle Monje-Deisseroth · Brigham And Women'S Hospital · U19 · FY2025 · CA

Migration of Human Neural Stem Cells In Vitro and In Vivo

$176,094
Alfredo Quinones-Hinojosa · Johns Hopkins University · K08 · FY2010 · NS

Migration of Human Neural Stem Cells In Vitro and In Vivo

$176,094
Alfredo Quinones-Hinojosa · Johns Hopkins University · K08 · FY2009 · NS